Andrew Lux - AtriCure Insider

AtriCure Inc -- USA Stock  

USD 18.32  0.29  1.61%

Sr. VP of Operations and Quality Assurance

Dr. Andrew L. Lux, Ph.D., is Senior Vice President Operations and Quality of AtriCure Inc. Dr. Lux previously served as our Vice President and Chief Operating Officer from 2012 to 2013. Prior to joining AtriCure, Dr. Lux served in leadership capacities at both small and large companies. From 2010 to 2012, Dr. Lux served as the Senior Vice President of Manufacturing and Operations for IntriMed Technologies, a startup business focused on contract manufacturing of implantable medical devices. From 2008 to 2010, Dr. Lux was the Vice President of Research and Development, Operations and Service for WaterHealth International, Inc., a business focused on the water purificationdisinfections markets. From 2006 to 2008, Dr. Lux was the General Manager for Medtronic, Inc.s spinal division in Warsaw, Indiana, where he was responsible for the United States based manufacturing organization providing spinal implant and orthopedic instrumentation products. Prior to 2006, Dr. Lux served in a variety of executive capacities for medical device organizations including Baxter Healthcare, Inc., Medtronic, Inc., Johnson Johnson and General Electric Company
Age: 64  SVP Since 2013  MBA    
513 755-4100
Lux received his M.S. and Ph.D. from M.I.T. and his M.B.A. from Case Western Reserve University.

Management Efficiency

The company has return on total asset (ROA) of (6.75) % which means that it has lost $6.75 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (19.82) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 38.69 M in liabilities with Debt to Equity (D/E) ratio of 24.3 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. AtriCure Inc has Current Ratio of 2.23 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Entity Summary

AtriCure, Inc., a medical device company, offer atrial fibrillation solutions to hospitals and medical centers in the United States and internationally. AtriCure Inc (ATRC) is traded on NASDAQ General Markets in USA. It is located in OHIO, U.S.A and employs 430 people. AtriCure is listed under Medical Equipment category by Fama And French industry classification.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add AtriCure Inc to your portfolio

Top Management

AtriCure Inc Leadership Team
Salvatore Privitera, CTO
Patricia Kennedy, President
Andrew Lux, SVP, MBA
Michael Hooven, Director
Karen Robards, Director, MBA
Justin Noznesky, President
Douglas Seith, COO
Andrew Wade, President, MBA
Regina Groves, Director
Kristine Johnson, Director
Scott Drake, Director
M Wade, President, MBA
Mark Collar, Director
Michael Carrel, CEO, MBA
Mark Lanning, Director
Richard Johnston, Chairman, MBA
Robert White, Director, MBA
Sven Wehrwein, Director
Elizabeth Krell, Director, Ph.D

Stock Performance

AtriCure Performance Indicators